Institute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Johann Wolfgang Goethe-University, Max-von-Laue-Str. 7+9, 60438, Frankfurt/M., Germany.
Saverna Therapeutics, Pumpmattenweg 3, 4105, Biel-Benken, Switzerland.
Angew Chem Int Ed Engl. 2021 Aug 23;60(35):19191-19200. doi: 10.1002/anie.202103693. Epub 2021 Aug 3.
SARS-CoV-2 contains a positive single-stranded RNA genome of approximately 30 000 nucleotides. Within this genome, 15 RNA elements were identified as conserved between SARS-CoV and SARS-CoV-2. By nuclear magnetic resonance (NMR) spectroscopy, we previously determined that these elements fold independently, in line with data from in vivo and ex-vivo structural probing experiments. These elements contain non-base-paired regions that potentially harbor ligand-binding pockets. Here, we performed an NMR-based screening of a poised fragment library of 768 compounds for binding to these RNAs, employing three different H-based 1D NMR binding assays. The screening identified common as well as RNA-element specific hits. The results allow selection of the most promising of the 15 RNA elements as putative drug targets. Based on the identified hits, we derive key functional units and groups in ligands for effective targeting of the RNA of SARS-CoV-2.
SARS-CoV-2 含有一条约 30000 个核苷酸的正链单链 RNA 基因组。在这个基因组中,有 15 个 RNA 元件被鉴定为与 SARS-CoV 和 SARS-CoV-2 之间保守。通过核磁共振(NMR)光谱学,我们之前已经确定这些元件独立折叠,与体内和体外结构探测实验的数据一致。这些元件包含可能含有配体结合口袋的无碱基配对区域。在这里,我们使用三种不同的基于 H 的 1D NMR 结合测定法,对一个由 768 个化合物组成的平衡片段文库进行了基于 NMR 的筛选,以检测这些 RNA 的结合情况。筛选鉴定出了常见的和 RNA 元件特异性的命中。结果允许选择最有前途的 15 个 RNA 元件作为潜在的药物靶点。基于鉴定出的命中,我们推导出配体中的关键功能单元和基团,以便有效地靶向 SARS-CoV-2 的 RNA。